HuGE Literature Finder
Records
1
-
4
Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer. PloS one 2021 16 (3): e0247989. Umamaheswaran Gurusamy, Kadambari Dharanipragada, Muthuvel Suresh Kumar, Kumar Naveena A N, Dubashi Biswajit, Aibor Dkhar Steven, Adithan Chandrasekar |
TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-?B Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response. Molecular pharmacology 2017 08 92 (2): 175-184. Ho Ming-Fen, Ingle James N, Bongartz Tim, Kalari Krishna R, Goss Paul E, Shepherd Lois E, Mushiroda Taisei, Kubo Michiaki, Wang Liewei, Weinshilboum Richard |
Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients. British journal of clinical pharmacology 2016 Oct . Gervasini Guillermo, Jara Carlos, Olier Clara, Romero Nuria, Martínez Ruth, Carrillo Juan Anton |
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
![]() Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Nov 28 (31): 4674-82. Ingle James N, Schaid Daniel J, Goss Paul E, Liu Mohan, Mushiroda Taisei, Chapman Judy-Anne W, Kubo Michiaki, Jenkins Gregory D, Batzler Anthony, Shepherd Lois, Pater Joseph, Wang Liewei, Ellis Matthew J, Stearns Vered, Rohrer Daniel C, Goetz Matthew P, Pritchard Kathleen I, Flockhart David A, Nakamura Yusuke, Weinshilboum Richard |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 01, 2023
- Content source: